Regulation & Compliance
Greenberg Wants Bernanke to Testify in Suit Challenging AIG Bailout
U.S. Federal Reserve Chairman Ben Bernanke shouldn't be compelled to testify in Maurice "Hank" Greenberg's lawsuit over the government's bailout of American International Group Inc., the Justice ...
U.K. Regulator Reviewing Insurance Add-On Products
The U.K. markets regulator is reviewing whether there is enough competition in insurance add- on products, which are sold along with purchases such as vacations or a car. The market study is looking ...
Insurer Insolvencies Fuel Director Liability; Board Roles Becoming More Complex
Member of boards of directors of insurance companies are increasingly concerned about lawsuits they might face in troubled situations—and they should be, according to a former insurance regulator. ...
Financial Industry Takes Cybersecurity Seriously: Judd Gregg
The financial industry has been under a constant state of attack for the past year as hackers attempt to steal clients' money, crash computer systems and disrupt capital markets. So far, the industry ...
S&P to Defend Credit Rating ‘Puffery’ in Case Over Fraud Charges
Standard & Poor's, getting its first shot in open court at U.S. Justice Department claims it should pay as much as $5 billion in civil penalties, will defend itself by arguing reasonable ...
Canada Train Explosion Spurs Debate Over Safety of Crude Oil Shipping
A train disaster that killed five people in Quebec promises to touch off debate over the safety of shipping crude oil by rail or pipelines such as TransCanada Corp.'s Keystone XL. As authorities ...
Europe’s Financial Regulation Scheme Still a Work in Progress
Five years after mismanagement brought the global financial system to the brink of collapse, a Reuters survey reveals yawning differences in the way European Union countries assess whether bankers ...
Drugmakers Search for Safer Painkillers Amid Opioid Abuse Epidemic
Backed by a U.S. campaign to slow abuse of prescription painkillers, drugmakers are devising new forms of the medicines that don't lead to misuse and new products that treat dependency in a bid to ...